Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sci Rep. 2022 Jul 23;12(1):12626. doi: 10.1038/s41598-022-16210-6.
Reduced left ventricular ejection fraction (LVEF) is associated with increased mortality after acute myocardial infarction (AMI). However, the prognostic impact of elevated systolic pulmonary artery pressure (sPAP) in the very elderly patients after AMI is lacking. We aimed to study the impact of elevated sPAP on one- and five-year all-cause mortality after AMI in very elderly patients, 80 years of age and older. Of a total number of 353 patients (≥ 80 years) who were hospitalized with acute coronary syndrome, 162 patients presenting with AMI and with available data of sPAP on echocardiography were included and followed-up for 5 years. The survival analyses were performed using Cox-Regression models adjusted for conventional risk factors including LVEF. Altogether 66 of 162 patients (41%) had ST-segment elevation MI, and 121 (75%) of patients were treated with percutaneous coronary intervention in the acute phase. Echocardiography during the admission revealed that 78 patients (48%) had a LVEF ≤ 45% and 66 patients (41%) had a sPAP ≥ 40 mmHg. After one and five years of follow-up, 23% (n = 33) and 53% (n = 86) of patients died, respectively. A multivariable Cox-Regression analysis showed that the elevated sPAP (≥ 40 mmHg) was an independent predictor of increased mortality in both one and five years after AMI; HR of 2.63 (95%, CI 1.19-5.84, P 0.017) and HR of 2.08 (95%, CI 1.25-3.44, P 0.005) respectively, whereas LVEF ≤ 45% did not show any statistically significant impact, neither on one- nor on five-year mortality (HR 1.3, 95% CI 0.6-2.9, p = 0.469) and (HR 1.4, 95% CI 0.8-2.4, p = 0.158), respectively. Elevated sPAP was an independent risk factor for one- and five-year all-cause mortality after AMI in very elderly patients and sPAP seems to be a better prognostic predictor for all-cause mortality than LVEF. The risk of all-cause mortality after AMI increased with increasing sPAP.
左心室射血分数(LVEF)降低与急性心肌梗死(AMI)后死亡率增加有关。然而,AMI 后非常高龄患者中升高的收缩期肺动脉压(sPAP)的预后影响尚不清楚。我们旨在研究非常高龄患者(≥80 岁)AMI 后升高的 sPAP 对 1 年和 5 年全因死亡率的影响。在因急性冠状动脉综合征住院的 353 名患者(≥80 岁)中,纳入了 162 名有 AMI 且超声心动图有 sPAP 数据的患者,并进行了 5 年的随访。使用 Cox 回归模型对包括 LVEF 在内的常规危险因素进行调整后,进行生存分析。共有 162 名患者中的 66 名(41%)发生 ST 段抬高型心肌梗死,121 名(75%)患者在急性期接受了经皮冠状动脉介入治疗。入院期间的超声心动图显示,78 名患者(48%)的 LVEF≤45%,66 名患者(41%)的 sPAP≥40mmHg。随访 1 年和 5 年后,分别有 23%(n=33)和 53%(n=86)的患者死亡。多变量 Cox 回归分析显示,升高的 sPAP(≥40mmHg)是 AMI 后 1 年和 5 年死亡率增加的独立预测因素;AMI 后 1 年的 HR 为 2.63(95%CI 1.19-5.84,P=0.017),AMI 后 5 年的 HR 为 2.08(95%CI 1.25-3.44,P=0.005),而 LVEF≤45%在 1 年和 5 年死亡率方面均无统计学意义(HR 1.3,95%CI 0.6-2.9,P=0.469)和(HR 1.4,95%CI 0.8-2.4,P=0.158)。升高的 sPAP 是非常高龄患者 AMI 后 1 年和 5 年全因死亡率的独立危险因素,sPAP 似乎比 LVEF 更能预测全因死亡率。AMI 后全因死亡率随 sPAP 的升高而增加。